BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: McKillop D, Wild MJ, Butters CJ, Simcock C. Effects of propofol on human hepatic microsomal cytochrome P450 activities. Xenobiotica. 1998;28:845-853. [PMID: 9764927 DOI: 10.1080/004982598239092] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Page VJ, Ely EW, Gates S, Zhao XB, Alce T, Shintani A, Jackson J, Perkins GD, McAuley DF. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2013;1:515-523. [PMID: 24461612 DOI: 10.1016/s2213-2600(13)70166-8] [Cited by in Crossref: 225] [Cited by in F6Publishing: 81] [Article Influence: 28.1] [Reference Citation Analysis]
2 Lejus C, Fautrel A, Mallédant Y, Guillouzo A. Inhibition of cytochrome P450 2E1 by propofol in human and porcine liver microsomes. Biochem Pharmacol 2002;64:1151-6. [PMID: 12234619 DOI: 10.1016/s0006-2952(02)01226-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 1] [Article Influence: 0.9] [Reference Citation Analysis]
3 Westhout FD, Muhonen MG, Nwagwu CI. Early propofol infusion syndrome following cerebral angiographic embolization for giant aneurysm repair. Case report. J Neurosurg 2007;106:139-42. [PMID: 17330542 DOI: 10.3171/ped.2007.106.2.139] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
4 Green T, Toghill A, Lee R, Waechter F, Weber E, Peffer R, Noakes J, Robinson M. Thiamethoxam induced mouse liver tumors and their relevance to humans. Part 2: species differences in response. Toxicol Sci 2005;86:48-55. [PMID: 15716476 DOI: 10.1093/toxsci/kfi125] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
5 Kanazawa H, Okada A, Igarashi E, Higaki M, Miyabe T, Sano T, Nishimura R. Determination of midazolam and its metabolite as a probe for cytochrome P450 3A4 phenotype by liquid chromatography–mass spectrometry. Journal of Chromatography A 2004;1031:213-8. [DOI: 10.1016/j.chroma.2003.12.039] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
6 Unger M, Frank A. Simultaneous determination of the inhibitory potency of herbal extracts on the activity of six major cytochrome P450 enzymes using liquid chromatography/mass spectrometry and automated online extraction. Rapid Commun Mass Spectrom 2004;18:2273-81. [DOI: 10.1002/rcm.1621] [Cited by in Crossref: 111] [Cited by in F6Publishing: 88] [Article Influence: 6.5] [Reference Citation Analysis]
7 Khojasteh SC, Prabhu S, Kenny JR, Halladay JS, Lu AY. Chemical inhibitors of cytochrome P450 isoforms in human liver microsomes: a re-evaluation of P450 isoform selectivity. Eur J Drug Metab Pharmacokinet 2011;36:1-16. [PMID: 21336516 DOI: 10.1007/s13318-011-0024-2] [Cited by in Crossref: 97] [Cited by in F6Publishing: 88] [Article Influence: 9.7] [Reference Citation Analysis]
8 Russell JL, Spiller HA, Baker DD. Markedly Elevated Carbamazepine-10,11-epoxide/Carbamazepine Ratio in a Fatal Carbamazepine Ingestion. Case Rep Med 2015;2015:369707. [PMID: 26550016 DOI: 10.1155/2015/369707] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Testino SA, Patonay G. High-throughput inhibition screening of major human cytochrome P450 enzymes using an in vitro cocktail and liquid chromatography–tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 2003;30:1459-67. [DOI: 10.1016/s0731-7085(02)00480-6] [Cited by in Crossref: 89] [Cited by in F6Publishing: 6] [Article Influence: 4.9] [Reference Citation Analysis]
10 Cao S, Li Y, Wang L, Cui J, Jia N, Li R, Zhao C, Wang C, Wu Y, Wen A. Synergistic analgesic effect of propofol-alfentanil combination through detecting the inhibition of cAMP signal pathway. J Pharm Pharmacol 2016;68:1170-6. [PMID: 27334358 DOI: 10.1111/jphp.12578] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
11 Stanford SC, Stanford BJ. Reply to J. L. Palmer — Postoperative delirium indicating an adverse drug interaction involving the selective serotonin reuptake inhibitor, paroxetine? J Psychopharmacol 2000;14:186-7. [DOI: 10.1177/026988110001400210] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
12 Campesi I, Fois M, Franconi F. Sex and gender aspects in anesthetics and pain medication. Handb Exp Pharmacol 2012;:265-78. [PMID: 23027455 DOI: 10.1007/978-3-642-30726-3_13] [Cited by in Crossref: 20] [Cited by in F6Publishing: 27] [Article Influence: 2.5] [Reference Citation Analysis]
13 Mccormick AD, Slamon DL, Lenz EM, Phillips PJ, King CD, Mckillop D, Roberts DW. In vitro metabolism of a triclyclic alkaloid (M445526) in human liver microsomes and hepatocytes. Xenobiotica 2008;37:972-85. [DOI: 10.1080/00498250701620718] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
14 Yamazaki H, Shimizu M, Nagashima T, Minoshima M, Murayama N. Rat Cytochrome P450 2C11 in Liver Microsomes Involved in Oxidation of Anesthetic Agent Propofol and Deactivated by Prior Treatment with Propofol. Drug Metab Dispos 2006;34:1803-5. [DOI: 10.1124/dmd.106.011627] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
15 Yang LQ, Yu WF, Cao YF, Gong B, Chang Q, Yang GS. Potential inhibition of cytochrome P450 3A4 by propofol in human primary hepatocytes. World J Gastroenterol 2003; 9(9): 1959-1962 [PMID: 12970884 DOI: 10.3748/wjg.v9.i9.1959] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
16 Bhateria M, Ramakrishna R, Puttrevu SK, Saxena AK, Bhatta RS. Enantioselective inhibition of Cytochrome P450-mediated drug metabolism by a novel antithrombotic agent, S002-333: Major effect on CYP2B6. Chemico-Biological Interactions 2016;256:257-65. [DOI: 10.1016/j.cbi.2016.07.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
17 Murayama N, Minoshima M, Shimizu M, Guengerich FP, Yamazaki H. Involvement of human cytochrome P450 2B6 in the ω - and 4-hydroxylation of the anesthetic agent propofol. Xenobiotica 2008;37:717-24. [DOI: 10.1080/00498250701449431] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
18 . XXXIV International Congress of the European Association of Poisons Centres and Clinical Toxicologists (EAPCCT) 27–30 May 2014, Brussels, Belgium. Clinical Toxicology 2014;52:295-443. [DOI: 10.3109/15563650.2014.906213] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Mckillop D, Mccormick AD, Miles GS, Phillips PJ, Pickup KJ, Bushby N, Hutchison M. In vitro metabolism of gefitinib in human liver microsomes. Xenobiotica 2008;34:983-1000. [DOI: 10.1080/02772240400015222] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 3.3] [Reference Citation Analysis]
20 Liu Y, Zhang J, Li W, Ma H, Sun J, Deng M, Yang L. Ginsenoside Metabolites, Rather Than Naturally Occurring Ginsenosides, Lead to Inhibition of Human Cytochrome P450 Enzymes. Toxicological Sciences 2006;91:356-64. [DOI: 10.1093/toxsci/kfj164] [Cited by in Crossref: 87] [Cited by in F6Publishing: 79] [Article Influence: 5.8] [Reference Citation Analysis]
21 Tanaka E, Takano Y, Inomata S, Toyooka H, Honda K. Premedication medicines do not cause drug metabolic interaction with propofol using human liver microsomes in vitro. Eur J Clin Pharmacol 2004;60:565-8. [PMID: 15351923 DOI: 10.1007/s00228-004-0807-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
22 Garib V, Niggemann B, Zänker KS, Brandt L, Kubens BS. Influence of non-volatile anesthetics on the migration behavior of the human breast cancer cell line MDA-MB-468. Acta Anaesthesiol Scand 2002;46:836-44. [PMID: 12139540 DOI: 10.1034/j.1399-6576.2002.460714.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
23 Campos SP, de Lurdes Pinto M, Gomes G, de Pinho PG, Monteiro JA, Félix LM, Branco PS, Ferreira LM, Antunes LM. Expression of CYP1A1 and CYP1A2 in the liver and kidney of rabbits after prolonged infusion of propofol. Experimental and Toxicologic Pathology 2016;68:521-31. [DOI: 10.1016/j.etp.2016.07.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
24 Coecke S, Rogiers V, Bayliss M, Castell J, Doehmer J, Fabre G, Fry J, Kern A, Westmoreland C. The Use of Long-term Hepatocyte Cultures for Detecting Induction of Drug Metabolising Enzymes: The Current Status. Altern Lab Anim 1999;27:579-638. [PMID: 25487865 DOI: 10.1177/026119299902700408] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
25 Skrobik Y, Laverdiere M. Why Candida sepsis should matter to ICU physicians. Crit Care Clin 2013;29:853-64. [PMID: 24094381 DOI: 10.1016/j.ccc.2013.06.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
26 Cruz-Hurtado M, López-González ML, Mondragón V, Sierra-Santoyo A. In vitro phase I metabolism of vinclozolin by human liver microsomes. Xenobiotica 2019;49:895-904. [PMID: 30215542 DOI: 10.1080/00498254.2018.1523485] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Lichtenbelt B, Mertens M, Vuyk J. Strategies to Optimise Propofol-Opioid Anaesthesia: . Clinical Pharmacokinetics 2004;43:577-93. [DOI: 10.2165/00003088-200443090-00002] [Cited by in Crossref: 45] [Cited by in F6Publishing: 33] [Article Influence: 2.6] [Reference Citation Analysis]
28 Swaisland HC, Ranson M, Smith RP, Leadbetter J, Laight A, Mckillop D, Wild MJ. Pharmacokinetic Drug Interactions of Gefitinib with Rifampicin, Itraconazole and Metoprolol: . Clinical Pharmacokinetics 2005;44:1067-81. [DOI: 10.2165/00003088-200544100-00005] [Cited by in Crossref: 105] [Cited by in F6Publishing: 95] [Article Influence: 6.6] [Reference Citation Analysis]
29 Rendic S. Summary of information on human CYP enzymes: human P450 metabolism data. Drug Metabolism Reviews 2002;34:83-448. [DOI: 10.1081/dmr-120001392] [Cited by in Crossref: 558] [Cited by in F6Publishing: 143] [Article Influence: 29.4] [Reference Citation Analysis]
30 Richert L, Tuschl G, Abadie C, Blanchard N, Pekthong D, Mantion G, Weber J, Mueller S. Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes. Toxicology and Applied Pharmacology 2009;235:86-96. [DOI: 10.1016/j.taap.2008.11.019] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 3.1] [Reference Citation Analysis]
31 Dilmaghanian S, Gerber JG, Filler SG, Sanchez A, Gal J. Enantioselectivity of inhibition of cytochrome P450 3A4 (CYP3A4) by ketoconazole: Testosterone and methadone as substrates. Chirality 2004;16:79-85. [DOI: 10.1002/chir.10294] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 3.0] [Reference Citation Analysis]